1. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? 
M. Arbyn, P.J.F. Snijders, C.J.L.M. Meijer, J. Berkhof, K. Cuschieri, B.J. Kocjan, M. Poljak 
Clinical Microbiology and Infection 
Volume 21, Issue 9, Pages (September 2015)
DOI: /j.cmi
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

2. Fig. 1
Relative sensitivity (left) and specificity (right) of hrHPV DNA or RNA assays compared to HC2 to detect CIN2+ in cervical cancer screening.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

3. Fig. 2
Relative sensitivity (left) and specificity (right) of hrHPV DNA or RNA assays compared to the GP5+/6+ PCR-EIA to detect CIN2+ in cervical cancer screening.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions